219 related articles for article (PubMed ID: 26221096)
21. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
[TBL] [Abstract][Full Text] [Related]
22. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
Ozcan SK; Mutlu B; Dündar D; Willke A
Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961
[TBL] [Abstract][Full Text] [Related]
23. Yeasts species distribution in Neonatal Intensive Care Units in northeast Argentina.
Giusiano GE; Mangiaterra M; Rojas F; Gómez V
Mycoses; 2004 Aug; 47(7):300-3. PubMed ID: 15310334
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: results of a 2-year (1996 to 1998) multicenter surveillance study in Quebec, Canada.
St-Germain G; Laverdière M; Pelletier R; Bourgault AM; Libman M; Lemieux C; Noël G
J Clin Microbiol; 2001 Mar; 39(3):949-53. PubMed ID: 11230409
[TBL] [Abstract][Full Text] [Related]
25. Antifungal drug resistance in pathogenic fungi.
Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
[TBL] [Abstract][Full Text] [Related]
26. [Yeast infections: causative agents and their antifungal resistance in hospitalized pediatric patients and HIV-positive adults].
Rodero L; Boutureira M; Demkura H; Burkett A; Fernández C; Losso M; Jáuregui Rueda H; Monticelli A; Vitale R; Canteros C; Hochenfellner F; Vivot W; Davel G
Rev Argent Microbiol; 1997; 29(1):7-15. PubMed ID: 9229726
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the VITEK 2 system to test the susceptibility of Candida spp., Trichosporon asahii and Cryptococcus neoformans to amphotericin B, flucytosine, fluconazole and voriconazole: a comparison with the M27-A3 reference method.
Cejudo MA; Gallego AG; Lacasa EC; Aller AI; Romero A; García JP; Andrés GQ; Martín-Mazuelos E
Med Mycol; 2010 Aug; 48(5):710-9. PubMed ID: 20109092
[TBL] [Abstract][Full Text] [Related]
28. Antifungal susceptibility in vitro determined by the Etest® for Candida obtained from the oral cavity of irradiated and elderly individuals.
Freitas EM; Monteiro LC; Fernandes MB; Martelli Junior H; Bonan PR; Nobre SA
Braz Dent J; 2015; 26(2):99-104. PubMed ID: 25831097
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital.
Bedini A; Venturelli C; Mussini C; Guaraldi G; Codeluppi M; Borghi V; Rumpianesi F; Barchiesi F; Esposito R
Clin Microbiol Infect; 2006 Jan; 12(1):75-80. PubMed ID: 16460550
[TBL] [Abstract][Full Text] [Related]
30. Antifungal susceptibility of bloodstream yeasts isolated at a public children's hospital in Brazil: comparison of the Etest and the AFST-EUCAST microdilution method.
Matsumoto FE; Dias AL; Melhem MS; Szeszs MW; Auler ME; Ruiz LS; Gonçalves da Silva E; Gandra RF; Paula CR
Can J Microbiol; 2007 Dec; 53(12):1300-6. PubMed ID: 18059562
[TBL] [Abstract][Full Text] [Related]
31. [Antifungal susceptibility of Candida spp. isolates from blood cultures in a five-year period (1997-2001)].
Durán MT; Velasco D; Canle D; Moure R; Villanueva R
Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):488-92. PubMed ID: 14572381
[TBL] [Abstract][Full Text] [Related]
32. [Fungal urinary infection: report no. 1].
Washida H; Tsugaya M; Hirao N; Sakagami H; Iwase Y
Hinyokika Kiyo; 1986 Oct; 32(10):1543-6. PubMed ID: 3565191
[TBL] [Abstract][Full Text] [Related]
33. Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi-centre study.
Schmalreck AF; Willinger B; Haase G; Blum G; Lass-Flörl C; Fegeler W; Becker K;
Mycoses; 2012 May; 55(3):e124-37. PubMed ID: 22233267
[TBL] [Abstract][Full Text] [Related]
34. Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities.
Wisplinghoff H; Ebbers J; Geurtz L; Stefanik D; Major Y; Edmond MB; Wenzel RP; Seifert H
Int J Antimicrob Agents; 2014 Jan; 43(1):78-81. PubMed ID: 24182454
[TBL] [Abstract][Full Text] [Related]
35. FREQUENCY OF Candida SPECIES IN A TERTIARY CARE HOSPITAL IN TRIANGULO MINEIRO, MINAS GERAIS STATE, BRAZIL.
Menezes Rde P; Ferreira JC; de Sá WM; Moreira Tde A; Malvino LD; de Araujo LB; Röder DV; Penatti MP; Candido RC; Pedroso Rdos S
Rev Inst Med Trop Sao Paulo; 2015; 57(3):185-91. PubMed ID: 26200956
[TBL] [Abstract][Full Text] [Related]
36. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases.
Richter SS; Galask RP; Messer SA; Hollis RJ; Diekema DJ; Pfaller MA
J Clin Microbiol; 2005 May; 43(5):2155-62. PubMed ID: 15872235
[TBL] [Abstract][Full Text] [Related]
37. Role of yeasts as nosocomial pathogens & their susceptibility to fluconazole & amphotericin B.
Prasad KN; Agarwal J; Dixit AK; Tiwari DP; Dhole TN; Ayyagari A
Indian J Med Res; 1999 Jul; 110():11-7. PubMed ID: 10709333
[TBL] [Abstract][Full Text] [Related]
38. Antifungal Activity of Chitosan-Coated Poly(lactic-co-glycolic) Acid Nanoparticles Containing Amphotericin B.
Ludwig DB; de Camargo LEA; Khalil NM; Auler ME; Mainardes RM
Mycopathologia; 2018 Aug; 183(4):659-668. PubMed ID: 29497926
[TBL] [Abstract][Full Text] [Related]
39. Distribution and Antifungal Susceptibility Pattern of Candida species at a Tertiary Hospital in Malaysia.
Mohamed NA; Pathmanathan SG; Hussin H; Zaini AB
J Infect Dev Ctries; 2018 Feb; 12(2):102-108. PubMed ID: 31825911
[TBL] [Abstract][Full Text] [Related]
40. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
Takakura S; Fujihara N; Saito T; Kudo T; Iinuma Y; Ichiyama S
J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
